Osteopontin and Cancer: Insights into Its Role in Drug Resistance

被引：17
|
作者：
Hao, Chengcheng [1 ,2 ]
Lane, Jane [2 ]
Jiang, Wen G. [2 ]
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Oncol, Beijing 100038, Peoples R China
[2] Cardiff Univ, Div Canc & Genet, Cardiff China Med Res Collaborat, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales
来源：
BIOMEDICINES | 2023年 / 11卷 / 01期
关键词：
osteopontin; cancer; drug resistance; molecular mechanism; LUNG-CANCER; EPIGENETIC MODIFICATIONS; EXPRESSION; CELLS; AUTOPHAGY; CISPLATIN; SENSITIVITY; BIOMARKER; HETEROGENEITY; MECHANISMS;
D O I：
10.3390/biomedicines11010197
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cancer is one of the leading causes of mortality worldwide. Currently, drug resistance is the main obstacle in cancer treatments with the underlying mechanisms of drug resistance yet to be fully understood. Osteopontin (OPN) is a member of the integrin binding glycophosphoprotein family that is overexpressed in several tumour types. It is involved in drug transport, apoptosis, stemness, energy metabolism, and autophagy, which may contribute to drug resistance. Thus, understanding the role of OPN in cancer drug resistance could be important. This review describes the OPN-based mechanisms that might contribute to cancer drug resistance, demonstrating that OPN may be a viable target for cancer therapy to reduce drug resistance in sensitive tumours.
引用
收藏
页数：18
相关论文
共 50 条
  • [31] Cancer drug resistance: The central role of the karyotype
    Duesberg, Peter
    Li, Ruhong
    Sachs, Rainer
    Fabarius, Alice
    Upender, Madhvi B.
    Hehlmann, Ruediger
    DRUG RESISTANCE UPDATES, 2007, 10 (1-2) : 51 - 58
  • [32] The role of alternative splicing in cancer drug resistance
    Siegfried, Zahava
    Karni, Rotem
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2018, 48 : 16 - 21
  • [33] Drug Resistance in Cancer Therapy and the Role of Epigenetics
    Asano, Takeshi
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2020, 87 (05) : 244 - 251
  • [34] Drug-metabolizing enzymes: role in drug resistance in cancer
    G. Kaur
    S. K. Gupta
    P. Singh
    V. Ali
    V. Kumar
    M. Verma
    Clinical and Translational Oncology, 2020, 22 : 1667 - 1680
  • [35] Drug-metabolizing enzymes: role in drug resistance in cancer
    Kaur, G.
    Gupta, S. K.
    Singh, P.
    Ali, V.
    Kumar, V.
    Verma, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (10): : 1667 - 1680
  • [36] Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors
    Samant, Charudatt
    Kale, Ramesh
    Pai, K. Sreedhara Ranganath
    Nandakumar, Krishnadas
    Bhonde, Mandar
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 729
  • [37] A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors
    Leask, Andrew
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 101 : 111 - 114
  • [38] Molecular insights into cancer drug resistance from a proteomics perspective
    An, Yao
    Zhou, Li
    Huang, Zhao
    Nice, Edouard C.
    Zhang, Haiyuan
    Huang, Canhua
    EXPERT REVIEW OF PROTEOMICS, 2019, 16 (05) : 413 - 429
  • [39] Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer
    Yang, Ruixue
    Yi, Mei
    Xiang, Bo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [40] Osteopontin as a multifaceted driver of bone metastasis and drug resistance
    Pang, Xiaocong
    Gong, Kan
    Zhang, Xiaodan
    Wu, Shiliang
    Cui, Yimin
    Qian, Bin-Zhi
    PHARMACOLOGICAL RESEARCH, 2019, 144 : 235 - 244
12345